RVNC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Revance Therapeutics Insider Trading History Chart

Revance Therapeutics Share Price & Price History

^$3.65

+0.30 (1.20%)

As of 02/6/2025 01:00 AM ET

Revance Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/16/2024	Erica Jordan	Insider	Sell	2,392	$3.80	$9,089.60	114,864
3/18/2024	Dustin S Sjuts	President	Sell	9,211	$5.04	$46,423.44	167,550
3/18/2024	Dwight Moxie	Insider	Sell	8,125	$5.04	$40,950.00	137,815
3/18/2024	Tobin Schilke	CFO	Sell	9,361	$5.04	$47,179.44	192,666
9/5/2023	Dwight Moxie	SVP	Sell	23,853	$17.81	$424,821.93	55,066
8/3/2023	Mark J. Foley	CEO	Sell	26,279	$22.57	$593,117.03	840,375
7/3/2023	Mark J. Foley	CEO	Sell	26,279	$24.94	$655,398.26	866,654
7/3/2023	Tobin Schilke	CFO	Sell	1,701	$25.04	$42,593.04	79,896
6/15/2023	Carey Oconnor Kolaja	Director	Sell	2,500	$28.24	$70,600.00	16,561
6/9/2023	Dustin S Sjuts	President	Sell	5,000	$30.82	$154,100.00	147,347
6/9/2023	Mark J. Foley	CEO	Sell	31,279	$30.72	$960,890.88	891,933
6/1/2023	Tobin Schilke	CFO	Sell	2,701	$30.57	$82,569.57	81,328
5/15/2023	Dustin S Sjuts	President	Sell	21,015	$34.55	$726,068.25	152,347
5/15/2023	Dwight Moxie	SVP	Sell	21,401	$34.55	$739,404.55	69,165
5/15/2023	Mark J. Foley	CEO	Sell	70,447	$34.55	$2,433,943.85	923,212
5/1/2023	Tobin Schilke	CFO	Sell	3,201	$31.70	$101,471.70	63,081
4/3/2023	Tobin Schilke	CFO	Sell	3,201	$32.15	$102,912.15	66,282
3/9/2023	Dustin S Sjuts	President	Sell	21,508	$31.59	$679,437.72	123,934
3/9/2023	Dwight Moxie	SVP	Sell	18,496	$31.59	$584,288.64	55,547
3/9/2023	Mark J. Foley	CEO	Sell	70,390	$31.59	$2,223,620.10	823,351
3/9/2023	Tobin Schilke	CFO	Sell	18,517	$31.59	$584,952.03	73,222
3/1/2023	Tobin Schilke	CFO	Sell	3,201	$33.50	$107,233.50	49,390
2/1/2023	Tobin Schilke	CFO	Sell	3,201	$34.60	$110,754.60	54,676
1/20/2023	Tobin Schilke	CFO	Sell	1,000	$31.00	$31,000.00	57,877
1/9/2023	Tobin Schilke	CFO	Sell	3,701	$27.16	$100,519.16	58,877

SEC Filings (Institutional Ownership Changes) for Revance Therapeutics (NASDAQ:RVNC)

97.70% of Revance Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revance Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	411,523	$1.25M	0.0%	-7.7%	0.394%
3/18/2025	CIBRA Capital Ltd	1,139,979	$3.47M	2.4%	N/A	1.092%
2/18/2025	GTS Securities LLC	22,590	$69K	0.0%	-19.9%	0.022%
2/18/2025	Alpine Global Management LLC	12,202	$37K	0.0%	N/A	0.012%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	237,409	$0.72M	0.0%	-10.5%	0.227%
2/17/2025	Two Sigma Investments LP	170,136	$0.52M	0.0%	+8.6%	0.163%
2/17/2025	Stonepine Capital Management LLC	23,264	$71K	0.1%	-97.2%	0.022%
2/17/2025	ProShare Advisors LLC	75,252	$0.23M	0.0%	+19.3%	0.072%
2/17/2025	Man Group plc	443,544	$1.35M	0.0%	+47.8%	0.425%
2/17/2025	Newtyn Management LLC	1,810,000	$5.50M	1.0%	N/A	1.734%
2/17/2025	Millennium Management LLC	1,551,372	$4.72M	0.0%	+1,028.2%	1.486%
2/17/2025	Fairfax Financial Holdings Ltd. Can	21,158	$64K	0.0%	N/A	0.020%
2/17/2025	FORA Capital LLC	60,868	$0.19M	0.0%	+487.1%	0.058%
2/17/2025	Deutsche Bank AG	89,736	$0.27M	0.0%	+43.1%	0.086%
2/17/2025	Cubist Systematic Strategies LLC	293,675	$0.89M	0.0%	+27.3%	0.281%
2/17/2025	Beryl Capital Management LLC	5,935,009	$18.04M	4.1%	N/A	5.685%
2/17/2025	BNP Paribas Financial Markets	13,662	$42K	0.0%	-44.0%	0.013%
2/17/2025	Ameriprise Financial Inc.	23,706	$72K	0.0%	+54.1%	0.023%
2/17/2025	Algert Global LLC	183,108	$0.56M	0.0%	+44.5%	0.175%
2/14/2025	Jane Street Group LLC	113,150	$0.34M	0.0%	-81.3%	0.108%
2/14/2025	Schonfeld Strategic Advisors LLC	13,400	$41K	0.0%	-91.7%	0.013%
2/14/2025	Northern Trust Corp	991,043	$3.01M	0.0%	+2.7%	0.949%
2/14/2025	Vazirani Asset Management LLC	350,000	$1.06M	3.3%	+250.0%	0.335%
2/14/2025	Susquehanna Fundamental Investments LLC	551,224	$1.68M	0.0%	N/A	0.528%
2/14/2025	Two Sigma Securities LLC	11,657	$35K	0.0%	N/A	0.011%
2/14/2025	Adage Capital Partners GP L.L.C.	1,653,689	$5.03M	0.0%	+57.5%	1.584%
2/14/2025	Price T Rowe Associates Inc. MD	103,915	$0.32M	0.0%	+8.2%	0.100%
2/14/2025	Alpine Global Management LLC	12,202	$37K	0.0%	N/A	0.012%
2/14/2025	Hsbc Holdings PLC	12,111	$37K	0.0%	-99.0%	0.012%
2/14/2025	MetLife Investment Management LLC	60,514	$0.18M	0.0%	+7.5%	0.058%
2/14/2025	Natixis	10,343	$31K	0.0%	N/A	0.010%
2/13/2025	Marshall Wace LLP	252,468	$0.77M	0.0%	-55.5%	0.242%
2/13/2025	GABELLI & Co INVESTMENT ADVISERS INC.	1,058,500	$3.22M	0.6%	+26.0%	1.014%
2/13/2025	Gamco Investors INC. ET AL	58,418	$0.18M	0.0%	+37.5%	0.056%
2/13/2025	Gabelli Funds LLC	1,262,487	$3.84M	0.0%	+15.7%	1.209%
2/13/2025	FIL Ltd	4,196,095	$12.76M	0.0%	+0.1%	4.020%
2/13/2025	Invesco Ltd.	63,537	$0.19M	0.0%	+12.6%	0.061%
2/13/2025	Wells Fargo & Company MN	49,373	$0.15M	0.0%	+27.6%	0.047%
2/12/2025	RPO LLC	17,969	$55K	0.1%	N/A	0.017%
2/12/2025	ExodusPoint Capital Management LP	297,458	$0.90M	0.0%	+138.0%	0.285%
2/12/2025	Slotnik Capital LLC	671,607	$2.04M	0.9%	N/A	0.643%
2/12/2025	Geode Capital Management LLC	2,297,582	$6.99M	0.0%	+0.3%	2.201%
2/12/2025	Franklin Resources Inc.	1,161,382	$3.53M	0.0%	-75.7%	1.113%
2/12/2025	Alliancebernstein L.P.	3,497,112	$10.63M	0.0%	+7.3%	3.350%
2/12/2025	Wellington Management Group LLP	411,523	$1.25M	0.0%	-7.7%	0.394%
2/12/2025	Norges Bank	161,000	$0.49M	0.0%	N/A	0.154%
2/12/2025	JPMorgan Chase & Co.	1,298,822	$3.95M	0.0%	-64.3%	1.244%
2/12/2025	Mint Tower Capital Management B.V.	187,443	$0.57M	0.1%	+212.4%	0.180%
2/11/2025	Corebridge Financial Inc.	51,761	$0.16M	0.0%	-7.0%	0.050%
2/11/2025	Vanguard Group Inc.	5,625,091	$17.10M	0.0%	-1.9%	5.389%
2/11/2025	LPL Financial LLC	13,375	$41K	0.0%	-68.8%	0.013%
2/11/2025	KLP Kapitalforvaltning AS	24,400	$74K	0.0%	N/A	0.023%
2/11/2025	Magnetar Financial LLC	2,556,345	$7.77M	0.2%	+2.2%	2.449%
2/10/2025	Commonwealth Equity Services LLC	49,333	$0.15M	0.0%	-36.8%	0.047%
2/10/2025	Skandinaviska Enskilda Banken AB publ	62,041	$0.19M	0.0%	-57.7%	0.059%
2/7/2025	Alpine Associates Management Inc.	2,349,966	$7.14M	0.4%	-43.5%	2.251%
2/7/2025	Candriam S.C.A.	299,039	$0.91M	0.0%	N/A	0.286%
2/6/2025	Charles Schwab Investment Management Inc.	797,299	$2.42M	0.0%	+0.8%	0.764%
2/5/2025	New York Life Investment Management LLC	295,670	$0.90M	0.0%	+114.9%	0.283%
2/4/2025	Los Angeles Capital Management LLC	76,725	$0.23M	0.0%	-14.6%	0.073%
2/4/2025	Bank of New York Mellon Corp	307,764	$0.94M	0.0%	-5.7%	0.295%
1/31/2025	Rice Hall James & Associates LLC	678,541	$2.06M	0.1%	-7.1%	0.650%
1/30/2025	Rhumbline Advisers	142,603	$0.43M	0.0%	+5.1%	0.137%
1/27/2025	Deltec Asset Management LLC	100,000	$0.30M	0.1%	N/A	0.096%
1/17/2025	Inspire Investing LLC	131,892	$0.40M	0.0%	+69.0%	0.126%
1/17/2025	SG Americas Securities LLC	73,488	$0.22M	0.0%	-4.5%	0.070%
1/13/2025	FNY Investment Advisers LLC	477,823	$1.45M	0.8%	+160.4%	0.458%
12/13/2024	Exome Asset Management LLC	347,600	$1.80M	1.2%	N/A	0.333%
12/3/2024	Oddo BHF Asset Management Sas	725,000	$3.76M	0.2%	N/A	0.695%
11/27/2024	Franklin Resources Inc.	4,784,658	$24.59M	0.0%	-23.6%	4.583%
11/20/2024	Virtu Financial LLC	23,129	$0.12M	0.0%	N/A	0.022%
11/16/2024	Geode Capital Management LLC	2,289,654	$11.89M	0.0%	-0.4%	2.183%
11/15/2024	XTX Topco Ltd	27,381	$0.14M	0.0%	-60.8%	0.026%
11/15/2024	Wellington Management Group LLP	446,027	$2.32M	0.0%	N/A	0.425%
11/15/2024	State Street Corp	2,433,963	$12.63M	0.0%	+6.6%	2.320%
11/15/2024	HighTower Advisors LLC	147,400	$0.77M	0.0%	-72.5%	0.141%
11/14/2024	Walleye Capital LLC	699,621	$3.63M	0.0%	-83.7%	0.667%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	265,210	$1.38M	0.0%	+11.5%	0.253%
11/14/2024	Stonepine Capital Management LLC	820,000	$4.26M	2.7%	-70.7%	0.782%
11/14/2024	FORA Capital LLC	10,367	$54K	0.0%	N/A	0.010%
11/13/2024	BNP Paribas Financial Markets	24,390	$0.13M	0.0%	-78.8%	0.023%
11/13/2024	FMR LLC	214,596	$1.11M	0.0%	+28.6%	0.205%
11/13/2024	Dynamic Technology Lab Private Ltd	17,001	$88K	0.0%	N/A	0.016%
11/12/2024	Algert Global LLC	126,730	$0.66M	0.0%	+1,167.3%	0.121%
11/12/2024	Charles Schwab Investment Management Inc.	790,837	$4.10M	0.0%	+5.5%	0.754%
11/9/2024	Intech Investment Management LLC	44,495	$0.23M	0.0%	N/A	0.042%
11/8/2024	Alpine Associates Management Inc.	4,162,861	$21.61M	1.0%	N/A	3.971%
11/7/2024	LMR Partners LLP	2,244,400	$11.65M	0.1%	N/A	2.141%
11/6/2024	Accredited Investors Inc.	12,845	$67K	0.0%	N/A	0.012%
11/5/2024	GSA Capital Partners LLP	20,819	$0.11M	0.0%	N/A	0.020%
11/4/2024	Los Angeles Capital Management LLC	89,825	$0.47M	0.0%	-22.8%	0.086%
10/28/2024	Rice Hall James & Associates LLC	730,190	$3.79M	0.2%	+2.5%	0.697%
10/25/2024	China Universal Asset Management Co. Ltd.	20,161	$0.11M	0.0%	+64.3%	0.019%
10/11/2024	Creative Planning	10,858	$56K	0.0%	N/A	0.010%
10/10/2024	Inspire Investing LLC	78,055	$0.41M	0.0%	-43.9%	0.074%
10/8/2024	Daymark Wealth Partners LLC	15,000	$78K	0.0%	-80.3%	0.014%
10/3/2024	SG Americas Securities LLC	76,963	$0.40M	0.0%	N/A	0.073%
8/21/2024	Stonepine Capital Management LLC	2,800,000	$7.20M	6.6%	+41.7%	2.681%
8/16/2024	Algert Global LLC	10,000	$26K	0.0%	-92.7%	0.010%
8/15/2024	The Manufacturers Life Insurance Company	42,296	$0.11M	0.0%	+29.4%	0.040%

Data available starting January 2016

Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DAXXIFY (DaxibotulinumtoxinA-lanm) for injection for the treatment of glabellar lines and cervical dystonia; has completed phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing OnabotulinumtoxinA, a biosimilar to BOTOX that is in preclinical stage. The company also offers Resilient Hyaluronic Acid (RHA) dermal filler for the correction of moderate to severe dynamic facial wrinkles; and RHA Redensity, a dermal filler for the treatment of moderate to severe dynamic perioral rhytids. It has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Today's Range

Now: $3.65

$3.65

50 Day Range

MA: $3.65

$3.65

52 Week Range

Now: $3.65

$2.76

$6.65

Volume

N/A

Average Volume

3,783,913 shs

Market Capitalization

$381.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Who are the company insiders with the largest holdings of Revance Therapeutics?: Revance Therapeutics' top insider investors include:
Tobin Schilke (CFO)
Dustin S Sjuts (President)
Dwight Moxie (Insider)
Erica Jordan (Insider)
Learn More about top insider investors at Revance Therapeutics.